-Reuters
Piper Sandler Maintains Overweight on American Well, Lowers Price Target to $5
Piper Sandler analyst Jessica Tassan maintains American Well (NYSE:AMWL) with a Overweight and lowers the price target from $6 to $5.
Related Posts
Goldman Sachs Maintains Buy on AZEK Co, Raises Price Target to $27
Goldman Sachs analyst Susan Maklari maintains AZEK Co (NYSE:AZEK) with a Buy and raises the price target from $21 to $27.
Altimmune Announced Trial Met Its Primary Endpoint in All Pemvidutide Treatment Groups
- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced topline results from its 24-week (12-week extension) trial of pemvidutide in subjects with NAFLD.